Analyst consensus rating
Bio Analyst Rating: Hold
Direct answer
Bio's consensus rating is Hold.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $335.00.
Forecast evidence checked October 18, 2026.
Get free Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $353.70
- Average price target
- $335.00
- High price target
- $390.00
- Low price target
- $280.00
- Low target gap
- -20.8%
- Target upside
- -5.3%
- High target gap
- +10.3%
- Target range width
- 31.1%
- Consensus rating
- Hold
- Analysts
- 3
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Bio?
Bio has a verified Hold consensus. The same dataset has an average price target of $335.00.
How far are Bio's low and high targets from the recorded price?
The low target implies -20.8%, while the high target implies +10.3%.
How many analysts are included in Bio's consensus?
The verified consensus includes 3 analysts.
How is Bio's target upside or downside calculated?
The average target of $335.00 is divided by the recorded price of $353.70, then one is subtracted to produce -5.3%. This does not guarantee a future return.
When was Bio's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.